Publications

Predictive cancer genomics–what do we need?

Authors: JD Brenton, C Caldas

E-pub date: 2 Aug 2003

Journal name: Lancet

What’s new in neuro-oncology? Recent advances in medulloblastoma.

Authors: DW Ellison, SC Clifford, A Gajjar, RJ Gilbertson

E-pub date: 1 Aug 2003

Journal name: Eur J Paediatr Neurol

Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials.

Authors: MO Leach, KM Brindle, JL Evelhoch, JR Griffiths, MR Horsman, A Jackson, G J...

E-pub date: 1 Aug 2003

Journal name: Br J Radiol

A survey of canine expressed sequence tags and a display of their annotations through a flexible web-based interface.

Authors: LE Palmer, AL O'Shaughnessy, RR Preston, L Santos, VS Balija, LU Nascimento...

E-pub date: 1 Aug 2003

Journal name: J Hered

Molecular imaging using magnetic resonance: new tools for the development of tumour therapy.

Authors: KM Brindle

E-pub date: 1 Aug 2003

Journal name: Br J Radiol

Double-Strand Break Recognition and Its Repair by Nonhomologous End Joining

Authors: JM Bradbury, SP Jackson

E-pub date: 1 Aug 2003

Journal name:

The PIKK Family of Protein Kinases

Authors: GCM Smith, SP Jackson

E-pub date: 1 Aug 2003

Journal name:

Medulloblastoma sensitivity to 17-allylamino-17-demethoxygeldanamycin requires MEK/ERKM.

Authors: C Calabrese, A Frank, K Maclean, R Gilbertson

E-pub date: 4 Jul 2003

Journal name: J Biol Chem

Filters

Research Groups

Core Facilities

Start date

End date

Predictive cancer genomics–what do we need?

What’s new in neuro-oncology? Recent advances in medulloblastoma.

Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials.

A survey of canine expressed sequence tags and a display of their annotations through a flexible web-based interface.

Molecular imaging using magnetic resonance: new tools for the development of tumour therapy.

Double-Strand Break Recognition and Its Repair by Nonhomologous End Joining

The PIKK Family of Protein Kinases

Medulloblastoma sensitivity to 17-allylamino-17-demethoxygeldanamycin requires MEK/ERKM.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Predictive cancer genomics–what do we need?

What’s new in neuro-oncology? Recent advances in medulloblastoma.

Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials.

A survey of canine expressed sequence tags and a display of their annotations through a flexible web-based interface.

Molecular imaging using magnetic resonance: new tools for the development of tumour therapy.

Double-Strand Break Recognition and Its Repair by Nonhomologous End Joining

The PIKK Family of Protein Kinases

Medulloblastoma sensitivity to 17-allylamino-17-demethoxygeldanamycin requires MEK/ERKM.